首页> 外文OA文献 >Antibody-Mediated and Cellular Immune Responses Induced in Naive Volunteers by Vaccination with Long Synthetic Peptides Derived from the Plasmodium vivax Circumsporozoite Protein
【2h】

Antibody-Mediated and Cellular Immune Responses Induced in Naive Volunteers by Vaccination with Long Synthetic Peptides Derived from the Plasmodium vivax Circumsporozoite Protein

机译:通过接种间日疟原虫环子孢子蛋白的长合成肽的疫苗接种,在幼稚志愿者中诱导的抗体介导和细胞免疫反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Plasmodium vivax circumsporozoite (CS) protein is a leading malaria vaccine candidate. We describe the characterization of specific immune responses induced in 21 malaria-naive volunteers vaccinated with long synthetic peptides derived from the CS protein formulated in Montanide ISA 720. Both antibody- and cell-mediated immune responses were analyzed. Antibodies were predominantly of IgG1 and IgG3 isotypes, recognized parasite proteins on the immunofluorescent antibody test, and partially blocked sporozoite invasion of hepatoma cell lines in vitro. Peripheral blood mononuclear cells from most volunteers (94%) showed IFN-γ production in vitro upon stimulation with both long signal peptide and short peptides containing CD8+ T-cell epitopes. The relatively limited sample size did not allow conclusions about HLA associations with the immune responses observed. In summary, the inherent safety and tolerability together with strong antibody responses, invasion blocking activity, and the IFN-γ production induced by these vaccine candidates warrants further testing in a phase II clinical trial.
机译:间日疟原虫环子孢子(CS)蛋白是领先的疟疾疫苗候选者。我们描述了特异免疫应答的特征,该特异性免疫应答是在21名未患疟疾的志愿者中诱导的,这些志愿者接种了源自Montanide ISA 720中配制的CS蛋白的长合成肽。同时分析了抗体介导的免疫应答和细胞介导的免疫应答。抗体主要为IgG1和IgG3同种型,在免疫荧光抗体测试中识别为寄生虫蛋白,并在体外部分阻断了子孢子侵袭肝癌细胞的作用。大多数志愿者(94%)的外周血单核细胞在被含有CD8 + T细胞表位的长信号肽和短肽刺激后,在体外均表现出IFN-γ的产生。相对有限的样本量无法得出有关HLA与观察到的免疫反应的结论。总之,这些候选疫苗引起的固有安全性和耐受性以及强大的抗体反应,侵袭阻断活性和IFN-γ产生,值得在II期临床试验中进行进一步测试。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号